Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | SELP | P16109 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21195685 | 1.00 | L3MBTL1 (0.47) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL29137572 | 0.85 | KMT2A (0.48) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL21195696 | 0.85 | KMT2A (0.48) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL21195676 | 0.85 | KMT2A (0.48) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL29137571 | 0.84 | L3MBTL1 (0.49) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL21195695 | 0.80 | L3MBTL1 (0.42) | L3MBTL1KMT2AMEN1 | |
| SCHEMBL1673967 | 0.77 | L3MBTL1 (0.63) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL14206021 | 0.76 | L3MBTL1 (0.56) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL13262234 | 0.76 | KMT2A (0.53) | L3MBTL1KMT2AMEN1SELP | |
| SCHEMBL2794837 | 0.76 | L3MBTL1 (0.58) | L3MBTL1KMT2AMEN1SELP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10851130-B2 | Chemical synthesis method of Plesiomonas shigelloides serotype O51 O-antigen oligosaccharide | JIANGNAN UNIVERSITY (CN) | 2020-12-01 | — | — | US | disclosed |
| US-20190233459-A1 | Chemical Synthesis Method of Plesiomonas Shigelloides Serotype O51 O-antigen Oligosaccharide | JIANGNAN UNIVERSITY (CN) | 2019-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190233459-A1 | Chemical Synthesis Method of Plesiomonas Shigelloides Serotype O51 O-antigen Oligosaccharide | DDOST, OSTC, OGA | L3MBTL1 3196/4885KMT2A 3470/4885MEN1 4394/4885 |
| US-10851130-B2 | Chemical synthesis method of Plesiomonas shigelloides serotype O51 O-antigen oligosaccharide | DDOST, OSTC, OGA | L3MBTL1 3196/4885KMT2A 3470/4885MEN1 4394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.